Groundbreaking Study Employing Sensonics International’s Products Reveals Weight Loss Medications Impair Taste Function
A new study published inPhysiology & Behavioruncovers significant sensory implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications commonly prescribed for weight loss and obesity management. Researchers at the University of Pennsylvania found that GLP-1 RAs significantly impair taste function across all five basic taste qualities: sweet, sour, salty, bitter, and umami (brothy). The study, […]